All Stories

  1. Chapter 3: Advancing school readiness for children with disabilities in low- and middle-income countries
  2. Combining filtered-sunlight phototherapy with kangaroo mother care in low-resource settings: further research needed
  3. Filtered-sunlight phototherapy for neonatal jaundice in low-resource settings: evidence for action
  4. Disability inclusion for early childhood care and development: the twin-track approach
  5. Filtered-sunlight phototherapy for neonatal hyperbilirubinemia: context matters
  6. Scoping review of evidence-based practice guidelines for the evaluation and care of young children with developmental disabilities in LMIC settings: evidence for action
  7. Filtered-sunlight phototherapy for newborns with moderate-to-severe hyperbilirubinemia: a randomized trial
  8. Advancing early childhood development for children with disabilities and the Global Disability Summit 2025
  9. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
  10. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  11. Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
  12. Brain health equity and the influence of social determinants across the life cycle
  13. Heliotherapy for neonates with severe-to-hazardous hyperbilirubinemia: a randomized controlled, non-inferiority trial
  14. Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
  15. Development of Measures for d/Deaf and Hard of Hearing Stigma: Introduction to the Special Supplement on Stigma Measurement Tools
  16. Bridging the gaps in health and social equity for disabled children in low‐ and middle‐income countries
  17. Early childhood development strategy for the world’s children with disabilities
  18. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  19. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a syst...
  20. Burden of disease scenarios for 204 countries
  21. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  22. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  23. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  24. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
  25. Family-Centered Early Intervention Deaf/Hard of Hearing (FCEI-DHH): Guiding Values
  26. Cerebral palsy in African paediatric populations: A scoping review
  27. Strategies for addressing the needs of children with or at risk of developmental disabilities in early childhood by 2030: a systematic umbrella review
  28. Family-Centered Early Intervention Deaf/Hard of Hearing (FCEI-DHH): Cultural & Global Implications
  29. Family-Centered Early Intervention Deaf/Hard of Hearing (FCEI-DHH): Foundation Principles
  30. Family-Centered Early Intervention Deaf/Hard of Hearing (FCEI-DHH): Structure Principles
  31. Family-Centered Early Intervention Deaf/Hard of Hearing (FCEI-DHH): Support Principles
  32. Family-Centered Early Intervention Deaf/Hard of Hearing (FCEI-DHH): Introduction
  33. Mapping heterogeneity in family planning indicators in Burkina Faso, Kenya, and Nigeria, 2000–2020
  34. Global Challenges After a Global Challenge: Lessons Learned from the COVID-19 Pandemic
  35. Heliotherapy for Neonates with Severe-to-Hazardous Hyperbilirubinaemia: A Randomised Controlled, Unblinded, Non-Inferiority Trial
  36. Estimating vaccine coverage in conflict settings using geospatial methods: a case study in Borno state, Nigeria
  37. Global progress towards early childhood development for children with disabilities, 2013–2023
  38. Neurodiversity and humanism in autism: An LMIC health care setting perspective
  39. Sustainable Development Goals summit 2023 and the global pledge on disability-focused early childhood development
  40. UNICEF and global leadership for disability inclusion in early childhood
  41. Universal research index: An inclusive metric to quantify scientific research output
  42. Global leadership is needed to optimize early childhood development for children with disabilities
  43. Editorial: Optimizing school readiness for children with developmental disabilities
  44. The Nurturing Care Framework and Children With Developmental Disabilities in LMICs
  45. Promoting school readiness in children with developmental disabilities in LMICs
  46. Global prevalence of developmental disabilities in children and adolescents: A systematic umbrella review
  47. Mapping Local Variations and the Determinants of Childhood Stunting in Nigeria
  48. Visibilizando la discapacidad: Mirando el otro lado
  49. Visualizando a deficiência: Vendo o outro lado
  50. Regard sur le handicap: Voir l'autre côté
  51. Disabilities in Early Childhood: A Global Health Perspective
  52. Global investments to optimise the health and wellbeing of children with disabilities: a call to action
  53. Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018
  54. The overlapping burden of the three leading causes of disability and death in sub-Saharan African children
  55. Viewing disability: Seeing the other side
  56. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  57. Revisiting the Role of Pediatricians for Optimal Early Childhood Development in LMICs
  58. Solid Fuel Use and Health in Developing Countries
  59. BMJ Paediatrics Openand the Global South: an open call towards editorial diversity and inclusion
  60. Global and regional prevalence of disabilities among children and adolescents: Analysis of findings from global health databases
  61. Prioritising rehabilitation in early childhood for inclusive education: a call to action
  62. Cerebral palsy and developmental intellectual disability in children younger than 5 years: Findings from the GBD-WHO Rehabilitation Database 2019
  63. Validation of the Decision model of the Burden of Hearing loss Across the Lifespan (DeciBHAL) in Chile, India, and Nigeria
  64. Child health, inclusive education and development
  65. The Role of Parenting Interventions in Optimizing School Readiness for Children With Disabilities in Low and Middle Income Settings
  66. Clarifying Best Practices for Early Childhood Development
  67. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study
  68. Accelerating progress on early childhood development for children under 5 years with disabilities by 2030
  69. Disability in children: a global problem needing a well-coordinated global action
  70. Global investment to reduce the burden of hearing loss
  71. Heliotherapy for Neonatal Hyperbilirubinemia: Some Clarifications and Update
  72. Revisiting the prevalence and population of children with neurological impairments in sub‐Saharan Africa
  73. Mapping Anemia in Women: Global Trends and Inequality
  74. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019
  75. Dismantling Structural Discrimination in Global Health
  76. Child Mortality Trends and Targets: GBD 2019 Findings
  77. Systemic racism in global health: a personal reflection
  78. Infant and Young Child Feeding Practices among Adolescent Mothers and Associated Factors in India
  79. Setting the record straight on measuring SDG 4.2.1 – Authors' reply
  80. Transforming global health through equity-driven funding
  81. Ear and Hearing Care Workforce: Current Status and its Implications: Erratum
  82. Mapping inequalities in exclusive breastfeeding in low- and middle-income countries, 2000–2018
  83. Subnational mapping of HIV incidence and mortality among individuals aged 15–49 years in sub-Saharan Africa, 2000–18: a modelling study
  84. Beyond pledges: academic journals in high-income countries can do more to decolonise global health
  85. The conundrum of a global tool for early childhood development to monitor SDG indicator 4.2.1
  86. Hearing loss prevalence and years lived with disability
  87. Accountability framework to decolonise global health
  88. Mapping routine measles vaccination in low- and middle-income countries
  89. Five insights from the Global Burden of Disease Study 2019
  90. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019
  91. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  92. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  93. Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17
  94. The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis
  95. Promoting Inclusive Early Childhood Development under the SDG Era
  96. Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17
  97. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  98. Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
  99. Global Burden of Childhood Epilepsy, Intellectual Disability, and Sensory Impairments
  100. Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017
  101. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3
  102. Infants affected by Rh sensitization: A 2-year Canadian National Surveillance Study
  103. GBD 2016. Occupational Carcinogens Collaborators
  104. Global and regional burden of chronic respiratory disease in 2016 arising from non-infectious airborne occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016
  105. Global and regional burden of disease and injury in 2016 arising from occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016
  106. Mapping child growth failure across low- and middle-income countries
  107. Mapping disparities in education across low- and middle-income countries
  108. Premature mortality in children with developmental disabilities
  109. Mapping 123 million neonatal, infant and child deaths between 2000 and 2017
  110. Hearing loss: rising prevalence and impact
  111. Bolajoko Olusanya: personal challenges, public health
  112. Hearing loss grades and the International classification of functioning, disability and health
  113. Correction to: Regional prevalence and determinants of exclusive breastfeeding in India
  114. Diseases, Injuries, and Risk Factors in Child and Adolescent Health, 1990 to 2017
  115. Department of Error
  116. Regional prevalence and determinants of exclusive breastfeeding in India
  117. Poor data produce poor models: children with developmental disabilities deserve better – Authors' reply
  118. Diarrhoea deaths and disability-adjusted life years attributable to suboptimal breastfeeding practices in Nigeria: findings from the global burden of disease study 2016
  119. Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  120. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
  121. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease ...
  122. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  123. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  124. Measuring progress of the health-related Sustainable Development Goals for 195 countries
  125. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  126. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  127. Department of Error
  128. Nurturing care for children with developmental disabilities: a moral imperative for sub-Saharan Africa
  129. Developmental disabilities among children younger than 5 years in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  130. Tuberculosis disease burden and attributable risk factors in Nigeria, 1990–2016
  131. Alcohol use and attributable disease burden in 195
  132. Neonatal hyperbilirubinaemia: a global perspective
  133. TV listening and hearing aids
  134. Measuring performance_Healthcare Access_Quality Index for 195 countries and territories
  135. RE: Global Initiatives for Early Childhood Development Should Be Disability Inclusive
  136. The Contribution of Neonatal Jaundice to Global Child Mortality: Findings From the GBD 2016 Study
  137. Timely sensory stimulation and early childhood development
  138. Burden of severe neonatal jaundice: a systematic review and meta-analysis
  139. Department of Error
  140. Severe neonatal hyperbilirubinaemia is frequently associated with long hospitalisation for emergency care in Nigeria
  141. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016
  142. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
  143. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  144. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  145. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  146. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016
  147. Department of Error
  148. Obligations under global health partnerships in LMICs should be contractual
  149. Maternal detection of neonatal jaundice during birth hospitalization using a novel two-color icterometer
  150. Adolescent health in the Eastern Mediterranean Region: findings from the global burden of disease 2015 study
  151. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015
  152. Child and Adolescent Health From 1990 to 2015
  153. A neurologic dysfunction scoring protocol for jaundiced neonates requiring exchange transfusion
  154. Transcutaneous bilirubin nomograms in African neonates
  155. Department of Error
  156. Global, Regional, and National Levels of Maternal Mortality, 1990–2015
  157. Department of Error
  158. Use of Transcutaneous Bilirubin to Determine the Need for Phototherapy in Resource-Limited Settings
  159. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  160. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  161. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  162. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
  163. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
  164. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  165. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015
  166. Correction to Lancet HIV 2016; 3: e361–87
  167. Differences Between Transcutaneous and Serum Bilirubin Measurements in Black African Neonates
  168. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015
  169. The authors reply
  170. Training pediatric emergency medicine specialists in India
  171. Irradiance Decay in Fluorescent and Light-emitting Diode-based Phototherapy Devices: A Pilot Study
  172. Heliotherapy for Neonatal Hyperbilirubinemia in Southwest, Nigeria: A Baseline Pre-Intervention Study
  173. Aging and Hearing Health: The Life-course Approach
  174. A decision-making tool for exchange transfusions in infants with severe hyperbilirubinemia in resource-limited settings
  175. Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013
  176. Predictors of Repeat Exchange Transfusion for Severe Neonatal Hyperbilirubinemia*
  177. The burden and management of neonatal jaundice in Nigeria: A scoping review of the literature
  178. Facility-based constraints to exchange transfusions for neonatal hyperbilirubinemia in resource-limited settings
  179. 10.1016/S0140-6736(15)60692-4
  180. Revisiting the Criteria for Exchange Transfusion for Severe Neonatal Hyperbilirubinemia in Resource-Limited Settings
  181. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition
  182. Infants at risk of significant hyperbilirubinemia in poorly-resourced countries: evidence from a scoping review
  183. A Randomized Trial of Phototherapy with Filtered Sunlight in African Neonates
  184. Structure, function and five basic needs of the global health research system
  185. Screening for neonatal deafness in resource-poor countries: challenges and solutions
  186. Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings
  187. A modified Bilirubin-induced neurologic dysfunction (BIND-M) algorithm is useful in evaluating severity of jaundice in a resource-limited setting
  188. Prevalence of Congenital Cytomegalovirus Infection in Nigeria
  189. Risk Factors for Severe Neonatal Hyperbilirubinemia in Low and Middle-Income Countries: A Systematic Review and Meta-Analysis
  190. Societal impact of bilirubin-induced hearing impairment in resource-limited nations
  191. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  192. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  193. Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  194. Addressing the burden of neonatal hyperbilirubinaemia in countries with significant glucose-6-phosphate dehydrogenase deficiency
  195. Why is kernicterus still a major cause of death and disability in low-income and middle-income countries?
  196. Maternal satisfaction with a novel filtered-sunlight phototherapy for newborn jaundice in Southwest Nigeria
  197. Newborn health research priorities beyond 2015
  198. Safety and Efficacy of Filtered Sunlight in Treatment of Jaundice in African Neonates
  199. Pattern and predictors of maternal care-seeking practices for severe neonatal jaundice in Nigeria: a multi-centre survey
  200. Letter to the Editor regarding ‘Hearing impairment, severe hyperbilirubinemia and heliotherapy’
  201. The global burden of disabling hearing impairment: a call to action
  202. Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels
  203. Letter to the Editor regarding ‘Investigating the burden of hyperbilirubinemia in resource-constrained settings’
  204. Evaluation of Window-Tinting Films for Sunlight Phototherapy
  205. Phototherapy Device Effectiveness in Nigeria: Irradiance Assessment and Potential for Improvement
  206. Pattern and Characteristics of Growth Faltering in Early Infancy in an Urban Sub-Saharan African Setting
  207. Treatment of neonatal jaundice with filtered sunlight in Nigerian neonates: study protocol of a non-inferiority, randomized controlled trial
  208. Risk of sensorineural hearing loss in infants with abnormal head size
  209. Full-term newborns with normal birthweight requiring special care in a resource-constrained setting
  210. Addressing the needs of adolescent mothers and their offspring in Nigeria: a community-based study
  211. Undernutrition and Hearing Impairment
  212. Paediatricians’ perspectives on global health priorities for newborn care in a developing country: a national survey from Nigeria
  213. Full-term newborns with congenital microcephaly and macrocephaly in Southwest Nigeria
  214. Neonatal hearing screening and intervention in resource-limited settings: an overview
  215. Perinatal Outcomes of Multiple Births in Southwest Nigeria
  216. Pattern of head growth and nutritional status of microcephalic infants at early postnatal assessment in a low-income country
  217. Maternal antecedents of infants with abnormal head sizes in southwest Nigeria: A community-based study
  218. Global and regional hearing impairment prevalence: an analysis of 42 studies in 29 countries
  219. Permanent Hearing Loss among Professional Spice Grinders in an Urban Community in Southwest Nigeria
  220. CHILD SURVIVAL AND CHILD DEVELOPMENT IN DEVELOPING COUNTRIES
  221. Perinatal correlates of delayed childbearing in a developing country
  222. Predictors of growth velocity in early infancy in a resource-poor setting
  223. Priorities for Early Childhood Development in Low-Income Countries
  224. Is home birth a marker for severe malnutrition in early infancy in urban communities of low-income countries?
  225. Highlights of the new WHO Report on Newborn and Infant Hearing Screening and implications for developing countries
  226. Maternal and neonatal profile of late-preterm survivors in a poorly resourced country
  227. Infants Delivered in Maternity Homes Run by Traditional Birth Attendants in Urban Nigeria: A Community-Based Study
  228. Making targeted screening for infant hearing loss an effective option in less developed countries
  229. Perinatal Outcomes Associated with Maternal Hypertensive Disorders of Pregnancy in a Developing Country
  230. Predictors of early-onset permanent hearing loss in malnourished infants in Sub-Saharan Africa
  231. Is discordance in TEOAE and AABR outcomes predictable in newborns?
  232. Surrogate measurements for identifying newborns with low birth weight in a community with predominant non-hospital births
  233. Prevalence, pattern and risk factors for undernutrition in early infancy using the WHO Multicentre Growth Reference: a community-based study
  234. Preference for private hospital-based maternity services in inner-city Lagos, Nigeria: An observational study
  235. Intrauterine growth restriction in a low-income country: Risk factors, adverse perinatal outcomes and correlation with current WHO Multicenter Growth Reference
  236. Ambient noise levels and infant hearing screening programs in developing countries: An observational report
  237. Reducing the burden of severe neonatal jaundice in G6PD-deficient populations in low-income countries: are we doing enough?
  238. Pattern and determinants of BCG immunisation delays in a sub-Saharan African community
  239. Telehealth in audiology: The need and potential to reach underserved communities
  240. Perinatal profile of very low birthweight infants under a universal newborn hearing screening programme in a developing country: A case-control study
  241. Hearing health-care delivery in sub-Saharan Africa – a role for tele-audiology
  242. NON-UPTAKE OF FACILITY-BASED MATERNITY SERVICES IN AN INNER-CITY COMMUNITY IN LAGOS, NIGERIA: AN OBSERVATIONAL STUDY
  243. Is undernutrition a risk factor for sensorineural hearing loss in early infancy?
  244. Predictors of term stillbirths in an inner-city maternity hospital in Lagos, Nigeria
  245. Predictors of Preterm Births and Low Birthweight in an Inner-City Hospital in Sub-Saharan Africa
  246. Maternal and neonatal factors associated with mode of delivery under a universal newborn hearing screening programme in Lagos, Nigeria
  247. Place of birth and characteristics of infants with congenital and early-onset hearing loss in a developing country
  248. Adverse neonatal outcomes associated with trial of labor after previous cesarean delivery in an inner-city hospital in Lagos, Nigeria
  249. Infants with HIV-infected mothers in a universal newborn hearing screening programme in Lagos, Nigeria
  250. Optimising the use of routine immunisation clinics for early childhood development in sub-Saharan Africa
  251. Sensorineural hearing loss in infants with neonatal jaundice in Lagos: a community-based study
  252. Correction
  253. Follow-up default in a hospital-based universal newborn hearing screening programme in a low-income country
  254. Newborns at risk of sensorineural hearing loss in low-income countries
  255. Community-based infant hearing screening in a developing country: parental uptake of follow-up services
  256. Universal infant hearing screening programme in a community with predominant non-hospital births: a three-year experience
  257. Costs and performance of early hearing detection programmes in Lagos, Nigeria
  258. Infants with severe neonatal jaundice in Lagos, Nigeria: incidence, correlates and hearing screening outcomes
  259. Predictors of term stillbirths in an inner-city maternity hospital in Lagos, Nigeria*
  260. Are risk factors for stillbirths in low-income countries associated with sensorineural hearing loss in survivors?
  261. Comment on Baltussen and SmithCost-effectiveness of selected interventions for hearing impairment in Africa and Asia: A mathematical modelling approach
  262. Community-based infant hearing screening for early detection of permanent hearing loss in Lagos, Nigeria: a cross-sectional study
  263. Non-hospital delivery and permanent congenital and early-onset hearing loss in a developing country
  264. The Need for Standardization of Methods for Worldwide Infant Hearing Screening: A Systematic Review
  265. Global Health Priorities for Developing Countries: Some Equity and Ethical considerations
  266. Hospital-based universal newborn hearing screening for early detection of permanent congenital hearing loss in Lagos, Nigeria
  267. Pitfalls in the diagnosis and management of transient synovitis of the hip: a retrospective case-note analysis
  268. Priorities for early hearing detection and intervention in sub-Saharan Africa
  269. Factors associated with auditory neuropathy/dys-synchrony in a developing country
  270. <p>Early hearing detection at immunization clinics in developing countries</p>
  271. A Hundred Horizons: The Indian Ocean in the Age of Global Empire (review)
  272. Correction: Addressing the Global Neglect of Childhood Hearing Impairment in Developing Countries
  273. Addressing the Global Neglect of Childhood Hearing Impairment in Developing Countries
  274. Global burden of childhood hearing impairment and disease control priorities for developing countries
  275. CORRECTION
  276. “The Right Stuff”: The Global Burden of Disease
  277. Progress towards early detection services for infants with hearing loss in developing countries
  278. Promoting effective interventions for neglected health conditions in developing countries
  279. Health priorities for developing countries: importance of non-fatal but disabling conditions
  280. Early detection of infant hearing loss: Current experiences of health professionals in a developing country
  281. Ethical issues in screening for hearing impairment in newborns in developing countries
  282. Adverse perinatal conditions in hearing-impaired children in a developing country
  283. Early hearing detection at immunization clinics in developing countries
  284. Reducing the Burden of Communication Disorders in the Developing World
  285. Revisiting the ten questions questionnaire for developing countries
  286. Stillbirths in sub-Saharan Africa
  287. Globalization of Infant Hearing Screening: The Next Challenge before JCIH?
  288. Communication disorders in Nigerian children
  289. Maternal views on infant hearing loss in a developing country
  290. Letter to the Editors: The burden of neonatal jaundice and sepsis in developing countries
  291. Disabilities, physicians and the millennium development goals
  292. Physician education on infant hearing loss in a developing country
  293. <p>Predictors of hearing loss in school entrants in a developing country</p>
  294. <p>Childhood deafness poses problems in developing countries</p>
  295. Screening for early childhood hearing loss in Nigeria
  296. Can the world's infants with hearing loss wait?
  297. State of the world's children: life beyond survival
  298. Childhood deafness poses problems in developing countries
  299. Infant hearing screening: route to informed choice
  300. Classification of childhood hearing impairment: implications for rehabilitation in developing countries
  301. Polio-vaccination boycott in Nigeria
  302. Corrigendum to “Benefits and challenges of newborn hearing screening for developing countries” [Int. J. Pediatr. Otorhinolaryngol. 68 (2004) 287–305]
  303. Benefits and challenges of newborn hearing screening for developing countries
  304. Self-reported outcomes of aural rehabilitation in a developing country
  305. Hearing impairment in children with impacted cerumen
  306. Early Detection of Hearing Impairment in a Developing Country: What Options?: Identificación temprana de problemas auditivos en países en desarrollo: ¿Qué opciones hay?
  307. Hearing impairment prevention in developing countries: making things happen
  308. The hearing profile of Nigerian school children
  309. West African children in private foster care in City and Hackney